Oncosec Medical (ONCS) |
|
4.17 -0.06 (-1.42%)
|
08-11 16:00 |
|
Open: |
4.53 |
Pre. Close: |
4.23 |
|
High:
|
5.4 |
Low:
|
4.13 |
|
Volume:
|
3,051,420 |
Market Cap:
|
96M |
|
|
|
|
OncoSec Medical Incorporated, a biotechnology company, focuses on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. Its lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. The company is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in the Phase IIb clinical trials (KEYNOTE-695) and advanced or metastatic triple negative breast cancer (TNBC), which is in the Phase II clinical trials (KEYNOTE-890); ImmunoPulse IL-12 and KEYTRUDA in patients with advanced or metastatic melanoma that has completed Phase II clinical trials; and ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma, which has completed the Phase II clinical trials. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
5.415 - 5.445 |
5.445 - 5.47 |
|
Low:
|
4.057 - 4.091 |
4.091 - 4.118 |
|
Close:
|
4.121 - 4.17 |
4.17 - 4.211 |
|
Technical analysis |
as of: 2020-08-11 4:34:32 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 6.31  One year: 7.37 |
| Support: |
Support1: 3.23 Support2: 1.89 |
| Resistance: |
Resistance1: 5.40 Resistance2: 6.31 |
| Pivot: |
4.00 |
| Moving Average: |
MA(5): 4.17  MA(20): 3.81
MA(100): 2.28 MA(250): 2.08 |
| MACD: |
MACD(12,26): 0.45 Signal(9): 0.47 |
| Stochastic oscillator: |
%K(14,3): 55.97 %D(3): 60.03 |
| RSI: |
RSI(14): 62.04 |
| 52-week: |
High: 5.40 Low: 1.04 Change(%): 94.9 |
| Average Vol(K): |
3-Month: 42673 10-Days: 67978 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.ONCS has closed below upper band by 40.5%. Bollinger Bands are 91.9% wider than normal. The large width of the bands suggest high volatility as compared to ONCS's normal range. The bands have been in this wide range for 20 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Tue, 11 Aug 2020
OncoSec Medical Incorporated (ONCS) is on the roll with an average volume of 388.98K in the recent 3 months - The InvestChronicle
Tue, 11 Aug 2020
Should You Buy OncoSec Medical Inc (ONCS) Stock? - InvestorsObserver
Mon, 10 Aug 2020
OncoSec to Present at the BTIG Virtual Biotechnology Conference 2020 on Tuesday, August 11, 2020 - WFMZ Allentown
Thu, 06 Aug 2020
Is OncoSec Medical Incorporated (NASDAQ:ONCS) Popular Amongst Institutions? - Yahoo Finance
Thu, 30 Jul 2020
OncoSec Medical Incorporated (ONCS) future in Healthcare Sector - The News Heater
Thu, 30 Jul 2020
Don’t Let Recent momentum Confuse Your Outlook on OncoSec Medical Incorporated [ONCS] - MZP News
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Capital Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
23 |
| Shares Float (M) |
9 |
|
% Held by Insiders
|
60.40 |
|
% Held by Institutions
|
7.90 |
|
Shares Short (K)
|
93 |
|
Shares Short P. Month (K)
|
140 |
Stock Financials |
|
EPS
|
-3.083 |
|
EPS Est This Year
|
-1.020 |
|
EPS Est Next Year
|
-0.820 |
|
Book Value (p.s.)
|
0.950 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-76.2 |
|
Return on Equity (ttm)
|
-190.2 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-1.741 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-32 |
|
Levered Free Cash Flow (M)
|
-16 |
Stock Valuations |
|
PE Ratio
|
-1.35 |
|
PEG Ratio
|
|
|
Price to Book value
|
4.39 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
-3.01 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
